Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v6.4)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-9

Query Trace: Li-Fraumeni Syndrome and BRCA2[orginal query]

Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor Similar articles in PubMed
Germline TP53 mutational spectrum in French Canadians with breast cancer. BMC medical genetics 2015 16 24. Arcand Suzanna L, Akbari Mohammed R, Mes-Masson Anne-Marie, Provencher Diane, Foulkes William D, Narod Steven A, Tonin Patricia Similar articles in PubMed
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson Similar articles in PubMed
Routine TP53 testing for breast cancer under age 30: ready for prime time? Familial cancer 2012 Aug . McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D Similar articles in PubMed
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast cancer research : BCR 2012 14 (2): R66. Lee Daphne S C, Yoon Sook-Yee, Looi Lai Meng, Kang Peter, Kang In Nee, Sivanandan Kavitta, Ariffin Hany, Thong Meow Keong, Chin Kin Fah, Mohd Taib Nur Aishah, Yip Cheng-Har, Teo Soo-Hwa Similar articles in PubMed
Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families. Breast cancer research and treatment 2008 Apr 108 (3): 399-408. Arcand Suzanna L, Maugard Christine M, Ghadirian Parviz, Robidoux André, Perret Chantal, Zhang Phil, Fafard Eve, Mes-Masson Anne-Marie, Foulkes William D, Provencher Diane, Narod Steven A, Tonin Patricia Similar articles in PubMed
CHEK2 1100delC is not a risk factor for male breast cancer population. International journal of cancer. Journal international du cancer 2004 Jan 108 (3): 475-6. Syrjäkoski Kirsi, Kuukasjärvi Tuula, Auvinen Anssi, Kallioniemi Olli Similar articles in PubMed
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. Journal of medical genetics 2002 Apr 39 (4): 225-42. de Jong M M, Nolte I M, te Meerman G J, van der Graaf W T A, Oosterwijk J C, Kleibeuker J H, Schaapveld M, de Vries E G Similar articles in PubMed
Mutation analysis of the CHK2 gene in families with hereditary breast cancer. British journal of cancer 2001 Jul 85 (2): 209-12. Allinen M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Mar 16, 2019
Page last updated:Sep 23, 2020
Content source:

TOP